Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Tuesday. The brokerage issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Trading Up 6.0 %

Arcadia Biosciences stock opened at $6.22 on Tuesday. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The firm has a market cap of $8.49 million, a P/E ratio of -1.45 and a beta of 1.18. The firm has a 50-day moving average of $4.03 and a 200-day moving average of $3.29.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.